Get the Stockscreener App
4.70
4.44%
0.20
After Hours:
4.70
Cumberland Pharmaceuticals Inc stock is traded at $4.70, with a volume of 32,244.
It is up +4.44% in the last 24 hours and up +13.25% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$4.50
Open:
$4.52
24h Volume:
32,244
Relative Volume:
0.03
Market Cap:
$62.86M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-6.4384
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
+4.44%
1M Performance:
+13.25%
6M Performance:
+294.96%
1Y Performance:
+170.11%
1-Day Range:
$4.52
$4.8699
1-Week Range:
$4.315
$4.8699
52-Week Range:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
2525 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
4.70 | 62.86M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World
Cumberland Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Cumberland: Q1 Earnings Snapshot - MySA
Cumberland Pharmaceuticals Inc Reports Q1 2025 Earnings: EPS at $0.16, Revenue Hits $11.7 Million - GuruFocus
Earnings call transcript: Cumberland Pharmaceuticals sees Q1 2025 revenue jump 38% - Investing.com
Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025 - TradingView
Cumberland Pharmaceuticals Inc.Common Stock (NQ: CPIX - FinancialContent
Renaissance Technologies LLC Sells 21,000 Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE - marketscreener.com
Cumberland Pharmaceuticals Q1 Earnings Call: Key Updates from Specialty Drug Portfolio Coming May 6 - Stock Titan
Cumberland Pharmaceuticals Shareholders Approve Key Proposals By Investing.com - Investing.com India
Cumberland Pharmaceuticals Shareholders Approve Key Proposals - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Cumberland Pharmaceuticals' (NASDAQ:CPIX) growing losses don't faze investors as the stock swells 18% this past week - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Cumberland Pharmaceuticals director Caroline Young acquires $383 in common stock - Investing.com Australia
Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals director James Jones buys shares worth $880 By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock - Investing.com
Cumberland Pharmaceuticals CEO A.J. Kazimi acquires $880 in common stock - Investing.com
Cumberland Pharmaceuticals director James Jones buys shares worth $880 - Investing.com India
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average – What’s Next? - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
FIGHT DMD trial results selected for late-breaking presentation at MDA clinical & scientific conference - Marketscreener.com
Breakthrough DMD Heart Disease Treatment Achieves 5.4% Function Boost While Controls Decline - Stock Titan
FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference - PR Newswire
Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Earnings call transcript: Cumberland Q4 2024 results show revenue rise By Investing.com - Investing.com Australia
CPIX Stock Price and Chart — NASDAQ:CPIX - TradingView
Cumberland Pharmaceuticals Inc. (CPIX) reports earnings - Quartz
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call Transcript - MSN
Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire
Cumberland Pharma stock soars to 52-week high of $7.25 By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals: Key Insights from Earnings Call - TipRanks
Cumberland Pharma stock soars to 52-week high of $7.25 - Investing.com India
Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Cumberland: Q4 Earnings Snapshot - Midland Daily News
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances - TipRanks
Earnings call transcript: Cumberland Q4 2024 results show revenue rise - Investing.com
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth - TradingView
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth -March 04, 2025 at 04:52 pm EST - Marketscreener.com
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):